Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Efficacy of Medical Cannabis in Fibromyalgia
Iftach Sagy, Lihi Bar‐Lev Schleider, Mahmoud Abu‐Shakra, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 6, pp. 807-807
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

One year in review 2021: fibromyalgia
Alessandra Alciati, Valeria Nucera, Ignazio Francesco Masala, et al.
Clinical and Experimental Rheumatology (2021) Vol. 39, Iss. 3, pp. 3-12
Open Access | Times Cited: 187
Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
Arun Bhaskar, Alan Bell, Michael Boivin, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 115
Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies
Massimo E. Maffei
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7877-7877
Open Access | Times Cited: 116
Current and Emerging Pharmacotherapy for Fibromyalgia
Roie Tzadok, Jacob N. Ablin
Pain Research and Management (2020) Vol. 2020, pp. 1-9
Open Access | Times Cited: 89
Pain in Women: A Perspective Review on a Relevant Clinical Issue that Deserves Prioritization
Roberto Casale, Fabiola Atzeni, Laura Bazzichi, et al.
Pain and Therapy (2021) Vol. 10, Iss. 1, pp. 287-314
Open Access | Times Cited: 86
Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies
Dena Zeraatkar, Matthew Cooper, Arnav Agarwal, et al.
BMJ Open (2022) Vol. 12, Iss. 8, pp. e054282-e054282
Open Access | Times Cited: 42
Pharmacological Treatment of Fibromyalgia Syndrome: A Practice-Based Review
Valeria Giorgi, Piercarlo Sarzi‐Puttini, Greta Pellegrino, et al.
Current Pain and Headache Reports (2024)
Open Access | Times Cited: 8
Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study
Philippe Lucas, Susan Boyd, M‐J Milloy, et al.
Pain Medicine (2020) Vol. 22, Iss. 3, pp. 727-739
Open Access | Times Cited: 66
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
Caroline A. MacCallum, Lindsay A. Lo, Michael Boivin
European Journal of Internal Medicine (2021) Vol. 89, pp. 10-18
Open Access | Times Cited: 52
A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?
Hajra Khurshid, Israa A Qureshi, Nasrin Jahan, et al.
Cureus (2021)
Open Access | Times Cited: 49
Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
Kevin F. Boehnke, Evangelos Litinas, Brianna Worthing, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 48
Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey
Kevin F. Boehnke, Joel Gagnier, Lynne Matallana, et al.
Journal of Pain (2021) Vol. 22, Iss. 11, pp. 1418-1428
Open Access | Times Cited: 42
Long‐term observational studies with cannabis‐based medicines for chronic non‐cancer pain: A systematic review and meta‐analysis of effectiveness and safety
Patric Bialas, Mary‐Ann Fitzcharles, Petra Klose, et al.
European Journal of Pain (2022) Vol. 26, Iss. 6, pp. 1221-1233
Open Access | Times Cited: 33
Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study
Lihi Bar‐Lev Schleider, Raphael Mechoulam, Inbal Sikorin, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 32
Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research
Stephanie Bourke, Anne Katrin Schlag, Saoirse E. O’Sullivan, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108216-108216
Open Access | Times Cited: 27
Beyond the Pain: A Systematic Narrative Review of the Latest Advancements in Fibromyalgia Treatment
Pothuri R Ram, Madhan Jeyaraman, Naveen Jeyaraman, et al.
Cureus (2023)
Open Access | Times Cited: 19
Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks
Samuel P Ang, Shawn Sidharthan, Wilson C. Lai, et al.
Pain and Therapy (2023) Vol. 12, Iss. 2, pp. 355-375
Open Access | Times Cited: 17
Cannabis for the Treatment of Fibromyalgia: A Systematic Review
Natalie Strand, Jillian Maloney, Molly B. Kraus, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1621-1621
Open Access | Times Cited: 16
A Cross-Sectional Survey Study of Cannabis Use for Fibromyalgia Symptom Management
Abhinav Singla, Christopher V. Anstine, Linda Huang, et al.
Mayo Clinic Proceedings (2024) Vol. 99, Iss. 4, pp. 542-550
Closed Access | Times Cited: 6
Post-reform cannabis use and major depressive episode: A naturalistic investigation
Sumona Hoque Mumu, Tayo Nafisat Folorunso, Jacqueline Pokuaa Badu, et al.
Journal of Contemporary Studies in Epidemiology and Public Health (2025) Vol. 6, Iss. 1, pp. ep25001-ep25001
Open Access
General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews
Mohammed Mohiuddin, Fiona Blyth, Louisa Degenhardt, et al.
Pain (2020) Vol. 162, Iss. 1, pp. S80-S96
Open Access | Times Cited: 48
Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia
Amnon A. Berger, Joseph Keefe, Ariel Winnick, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 34, Iss. 3, pp. 617-631
Closed Access | Times Cited: 42
Consensus‐based recommendations for titrating cannabinoids and tapering opioids for chronic pain control
Aaron Sihota, Brennan K. Smith, Sana‐Ara Ahmed, et al.
International Journal of Clinical Practice (2020) Vol. 75, Iss. 8
Open Access | Times Cited: 42
Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review
Inna Kurlyandchik, Evelin Tiralongo, Janet Schloss
The Journal of Alternative and Complementary Medicine (2020) Vol. 27, Iss. 3, pp. 198-213
Closed Access | Times Cited: 41
Review of Fibromyalgia (FM) Syndrome Treatments
Liraz Cohen-Biton, Dan Buskila, Rachel Nissanholtz‐Gannot
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 12106-12106
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top